Dare Bioscience Stock (NASDAQ: DARE) stock price, news, charts, stock research, profile.
Open | $0.300 |
Close | - |
Volume / Avg. | 69.646K / 666.164K |
Day Range | 0.300 - 0.312 |
52 Wk Range | 0.270 - 1.060 |
Market Cap | $31.180M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | 0.25% |
Days to Cover | 1.3 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Dare Bioscience (NASDAQ: DARE) through any online brokerage.
Other companies in Dare Bioscience’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and CalciMedica (NASDAQ:CALC).
The latest price target for Dare Bioscience (NASDAQ: DARE) was reported by HC Wainwright & Co. on Wednesday, May 1, 2024. The analyst firm set a price target for 6.00 expecting DARE to rise to within 12 months (a possible 1900.00% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Dare Bioscience (NASDAQ: DARE) is $0.3 last updated Today at May 7, 2024 at 9:17 AM EDT.
There are no upcoming dividends for Dare Bioscience.
Dare Bioscience’s Q1 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for Dare Bioscience.
Dare Bioscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.